Common Genetic Variation in GLP1R and Insulin Secretion in Response to Exogenous GLP-1 in Nondiabetic Subjects
Open Access
- 1 September 2010
- journal article
- clinical trial
- Published by American Diabetes Association in Diabetes Care
- Vol. 33 (9), 2074-2076
- https://doi.org/10.2337/dc10-0200
Abstract
OBJECTIVE: Glucagon-like peptide (GLP)-1 receptor is encoded by GLP1R. The effect of genetic variation at this locus on the response to GLP-1 is unknown. This study assessed the effect of GLP1R polymorphisms on insulin secretion in response to hyperglycemia and to infused GLP-1 in nondiabetic subjects. RESEARCH DESIGN AND METHODS: Eighty-eight healthy individuals (aged 26.3 ± 0.6 years, fasting glucose 4.83 ± 0.04 mmol/l) were studied using a hyperglycemic clamp. GLP-1 was infused for the last 2 h of the study (0.75 pmol/kg/min over 121–180 min, 1.5 pmol/kg/min over 181–240 min). β-Cell responsivity (ΦTotal) was measured using a C-peptide minimal model. The effect of 21 tag single nucleotide polymorphisms (SNPs) in GLP1R on ΦTotal was examined. RESULTS: Two SNPs (rs6923761 and rs3765467) were nominally associated with altered β-cell responsivity in response to GLP-1 infusion. CONCLUSIONS: Variation in GLP1R may alter insulin secretion in response to exogenous GLP-1. Future studies will determine whether such variation accounts for interindividual differences in response to GLP-1–based therapy.Keywords
This publication has 11 references indexed in Scilit:
- A model of GLP-1 action on insulin secretion in nondiabetic subjectsAmerican Journal of Physiology-Endocrinology and Metabolism, 2010
- Genomics of type 2 diabetes mellitus: implications for the clinicianNature Reviews Endocrinology, 2009
- Dipeptidyl Peptidase-4 Inhibition by Vildagliptin and the Effect on Insulin Secretion and Action in Response to Meal Ingestion in Type 2 DiabetesDiabetes Care, 2009
- Incretin effect potentiates β-cell responsivity to glucose as well as to its rate of change: OGTT and matched intravenous studyAmerican Journal of Physiology-Endocrinology and Metabolism, 2007
- A human glucagon-like peptide-1 receptor polymorphism results in reduced agonist responsivenessRegulatory Peptides, 2005
- Extrapancreatic Effects of GIP and GLP-1Hormone and Metabolic Research, 2004
- Insertion of an N-Terminal 6-Aminohexanoic Acid after the 7 Amino Acid Position of Glucagon-Like Peptide-1 Produces a Long-Acting Hypoglycemic AgentEndocrinology, 2001
- Insertion of an N-Terminal 6-Aminohexanoic Acid after the 7 Amino Acid Position of Glucagon-Like Peptide-1 Produces a Long-Acting Hypoglycemic AgentEndocrinology, 2001
- Oral Glucose Tolerance Test Minimal Model Indexes of β-Cell Function and Insulin SensitivityDiabetes, 2001
- More powerful procedures for multiple significance testingStatistics in Medicine, 1990